These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 23771798)
1. The expression of hepatoma-derived growth factor in primary central nervous system lymphoma and its correlation with angiogenesis, proliferation and clinical outcome. Li SZ; Zhao YB; Cao WD; Qu Y; Luo P; Zhen HN; Chen XY; Yan ZF; Fei Z Med Oncol; 2013; 30(3):622. PubMed ID: 23771798 [TBL] [Abstract][Full Text] [Related]
2. Hepatoma-derived growth factor as a prognostic marker in completely resected non-small-cell lung cancer. Iwasaki T; Nakagawa K; Nakamura H; Takada Y; Matsui K; Kawahara K Oncol Rep; 2005 Jun; 13(6):1075-80. PubMed ID: 15870924 [TBL] [Abstract][Full Text] [Related]
3. Upregulation of nucleus HDGF predicts poor prognostic outcome in patients with penile squamous cell carcinoma bypass VEGF-A and Ki-67. Li D; Han Z; Liu J; Zhang X; Ren J; Yan L; Liu H; Xu Z Med Oncol; 2013 Dec; 30(4):702. PubMed ID: 23999841 [TBL] [Abstract][Full Text] [Related]
4. Expression of hepatoma-derived growth factor in hepatocellular carcinoma. Hu TH; Huang CC; Liu LF; Lin PR; Liu SY; Chang HW; Changchien CS; Lee CM; Chuang JH; Tai MH Cancer; 2003 Oct; 98(7):1444-56. PubMed ID: 14508832 [TBL] [Abstract][Full Text] [Related]
5. Identification of hepatoma-derived growth factor as a potential prognostic and diagnostic marker for extrahepatic cholangiocarcinoma. Han Y; Zhang W; Liu Y World J Surg; 2013 Oct; 37(10):2419-27. PubMed ID: 23793608 [TBL] [Abstract][Full Text] [Related]
6. Hepatoma-derived growth factor induces tumorigenesis in vivo through both direct angiogenic activity and induction of vascular endothelial growth factor. Okuda Y; Nakamura H; Yoshida K; Enomoto H; Uyama H; Hirotani T; Funamoto M; Ito H; Everett AD; Hada T; Kawase I Cancer Sci; 2003 Dec; 94(12):1034-41. PubMed ID: 14662017 [TBL] [Abstract][Full Text] [Related]
8. High nuclear expression of HDGF correlates with disease progression and poor prognosis in human endometrial carcinoma. Wang L; Jiang Q; Hua S; Zhao M; Wu Q; Fu Q; Fang W; Guo S Dis Markers; 2014; 2014():298795. PubMed ID: 24692842 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma. Shih TC; Tien YJ; Wen CJ; Yeh TS; Yu MC; Huang CH; Lee YS; Yen TC; Hsieh SY J Hepatol; 2012 Sep; 57(3):584-91. PubMed ID: 22613005 [TBL] [Abstract][Full Text] [Related]
10. Increased expression of hepatoma-derived growth factor correlates with poor prognosis in human nasopharyngeal carcinoma. Wang S; Fang W Histopathology; 2011 Jan; 58(2):217-24. PubMed ID: 21255068 [TBL] [Abstract][Full Text] [Related]
11. Expression of hepatoma-derived growth factor is a strong prognostic predictor for patients with early-stage non-small-cell lung cancer. Ren H; Tang X; Lee JJ; Feng L; Everett AD; Hong WK; Khuri FR; Mao L J Clin Oncol; 2004 Aug; 22(16):3230-7. PubMed ID: 15310766 [TBL] [Abstract][Full Text] [Related]
12. The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors. Hu TH; Lin JW; Chen HH; Liu LF; Chuah SK; Tai MH Dis Colon Rectum; 2009 Feb; 52(2):319-26. PubMed ID: 19279430 [TBL] [Abstract][Full Text] [Related]
13. Prognostic value of nuclear hepatoma-derived growth factor (HDGF) localization in patients with breast cancer. Chen X; Yun J; Fei F; Yi J; Tian R; Li S; Gan X Pathol Res Pract; 2012 Aug; 208(8):437-43. PubMed ID: 22682760 [TBL] [Abstract][Full Text] [Related]
14. Positive feedback loop of hepatoma-derived growth factor and β-catenin promotes carcinogenesis of colorectal cancer. Lian J; Tang J; Shi H; Li H; Zhen T; Xie W; Zhang F; Yang Y; Han A Oncotarget; 2015 Oct; 6(30):29357-74. PubMed ID: 26296979 [TBL] [Abstract][Full Text] [Related]
15. Analysis of expression levels of markers associated with tumor proliferation and angiogenesis in familial adenomatous polyposis. Zhang Z; Wang D; Xu C; Li Y; Yu Y; Chen C; Li M; Zhang X Mol Genet Genomic Med; 2020 Dec; 8(12):e1534. PubMed ID: 33108070 [TBL] [Abstract][Full Text] [Related]
16. Hepatoma-derived growth factor/nucleolin axis as a novel oncogenic pathway in liver carcinogenesis. Chen SC; Hu TH; Huang CC; Kung ML; Chu TH; Yi LN; Huang ST; Chan HH; Chuang JH; Liu LF; Wu HC; Wu DC; Chang MC; Tai MH Oncotarget; 2015 Jun; 6(18):16253-70. PubMed ID: 25938538 [TBL] [Abstract][Full Text] [Related]
17. Expression of hepatoma-derived growth factor is correlated with lymph node metastasis and prognosis of gastric carcinoma. Yamamoto S; Tomita Y; Hoshida Y; Takiguchi S; Fujiwara Y; Yasuda T; Doki Y; Yoshida K; Aozasa K; Nakamura H; Monden M Clin Cancer Res; 2006 Jan; 12(1):117-22. PubMed ID: 16397032 [TBL] [Abstract][Full Text] [Related]
18. Expression level of hepatoma-derived growth factor correlates with tumor recurrence of esophageal carcinoma. Yamamoto S; Tomita Y; Hoshida Y; Morii E; Yasuda T; Doki Y; Aozasa K; Uyama H; Nakamura H; Monden M Ann Surg Oncol; 2007 Jul; 14(7):2141-9. PubMed ID: 17473954 [TBL] [Abstract][Full Text] [Related]
19. Up-regulation of hepatoma-derived growth factor facilitates tumor progression in malignant melanoma [corrected]. Tsai HE; Wu JC; Kung ML; Liu LF; Kuo LH; Kuo HM; Chen SC; Chan EC; Wu CS; Tai MH; Liu GS PLoS One; 2013; 8(3):e59345. PubMed ID: 23536873 [TBL] [Abstract][Full Text] [Related]
20. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer. Sun J; Min H; Yu L; Yu G; Shi Y; Sun J Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]